- PMID: 39108238
- PMCID: PMC11303855
- DOI: 10.1093/jncimonographs/lgad030
Abstract
Background: We assessed patient costs associated with cannabis use during cancer treatment.
Methods: Adults treated for cancer at a large, comprehensive center completed an anonymous survey regarding their thoughts and experiences with cannabis and cancer. Bivariate and weighted multivariable logistic regression assessed clinical and sociodemographic factors associated with patient-reported out-of-pocket costs for cannabis products.
Results: Overall, 248 cannabis users provided data on cost and were analyzed. Median monthly out-of-pocket cost for cannabis was $80 (interquartile range = $25-$150). On regression analysis, male gender (odds ratio = 2.5, 95% confidence interval = 1.2 to 5.5, P = .026) and being 45 years of age or older (odds ratio = 7.5, 95% confidence interval = 1.9 to 30.0, P = .0042) were associated with spending $100 a month or more on cannabis. Of the 166 patients who stopped using cannabis early or used less than preferred, 28% attributed it to cost and 26% to lack of insurance coverage.
Conclusion: Cannabis use during cancer treatment may contribute to significant out-of-pocket costs, with men and younger patients more likely to pay higher costs.
© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
The authors of this manuscript have no conflicts of interest to disclose.
Similar articles
-
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.JAMA Oncol. 2017 Jun 1;3(6):757-765. doi: 10.1001/jamaoncol.2016.4865.PMID: 27893028 Free PMC article.
-
Financial Burden in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.J Clin Oncol. 2017 Oct 20;35(30):3474-3481. doi: 10.1200/JCO.2016.71.7066. Epub 2017 Aug 17.PMID: 28817372 Free PMC article.
-
Patient-Provider Discussion About Cancer Treatment Costs and Out-of-Pocket Spending: Implications for Shared Decision Making in Cancer Care.Value Health. 2020 Dec;23(12):1592-1598. doi: 10.1016/j.jval.2020.08.002. Epub 2020 Sep 12.PMID: 33248514
-
Out-of-Pocket Spending and Premium Contributions After Implementation of the Affordable Care Act.JAMA Intern Med. 2018 Mar 1;178(3):347-355. doi: 10.1001/jamainternmed.2017.8060.PMID: 29356828 Free PMC article.
-
Concerns of Patients With Cancer on Accessing Cannabis Products in a State With Restrictive Medical Marijuana Laws: A Survey Study.J Oncol Pract. 2019 Oct;15(10):531-538. doi: 10.1200/JOP.19.00184. Epub 2019 Aug 23.PMID: 31442099 Free PMC article. Review.
Cited by
-
Overview of cancer patient perspectives on cannabis use during treatment.J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):199-201. doi: 10.1093/jncimonographs/lgae025.PMID: 39108236 Free PMC article. Review.
References
-
- Weinberger AH, Wyka K, Goodwin RD. Impact of cannabis legalization in the United States on trends in cannabis use and daily cannabis use among individuals who smoke cigarettes. Drug Alcohol Depend. 2022;238:109563. – PubMed
-
- Chiu V, Leung J, Hall W, et al. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology. 2021;193:108610. – PubMed